Dasatinib Active Not Recruiting Phase 2 Trials for Chronic Phase of Chronic Myeloid Leukemia

IndicationsStatusPurposePhase
Active Not RecruitingNot Available2
clinicaltrials.gov IdentifierTitleDrugs
NCT01872442Combination of Dasatinib and Peg-Interferon Alpha 2b in First Line for Chronic Myeloid Leukemia in Chronic Phase